Predictmedix AI Provides Update on Commercialization of Safe Entry with the Indonesian Healthcare Sector
TORONTO, ON / ACCESSWIRE / July 28, 2023 / Predictmedix Inc. ("Predictmedix" or the "Company") (CSE:PMED) (OTCQB:PMEDF) (FRA:3QP), a leading provider of rapid health screening...
Predictmedix Announces Production of AI-Powered Mobile Application to Rapidly Detect Impairment from Alcohol and Cannabis
Predictmedix has begun production of its mobile application for detecting impairment from cannabis and alcoholPredictmedix's screening to identify impairment takes less than 30 secondsThe mobile...
Predictmedix Announces Completion of 1600-Person Clinical Study for Safe Entry’s Medical Device Regulatory Approval in Indonesia
The 1600-person study at a prestigious University in Jakarta, Indonesia prepares Predictmedix's Safe Entry for regulatory approval listed as a ‘Medical Device'Medical device classification allows...